Neothetics Cmn (NASDAQ:NEOT) shares traded -18.04% down during most recent session to reach at the closing price of $0.38. The stock exchanged hands 1.95 Million shares versus average trading capacity of 819.68 Million shares, yielding a market cap of $4.69 Million. Wall Street analysts covering the stock are projecting that the stock will reach $3 within the next 52-weeks. The mean target projections are based on 1 opinions.
Taking a broader look brokerage firms’ analysts on the street with an expectant view have Neothetics Cmn (NASDAQ:NEOT) high price target of $3 and with a conservative view have low price target of $3.
PiperJaffray “Downgrades” Neothetics Cmn (NASDAQ:NEOT) in a research note issued to investors on 12/15/15 to Neutral.
On the other hand the company has Relative Strength Index (RSI 14) of 28.02 along with Average True Range (ATR 14) of 0.08, Consequently Neothetics Cmn (NASDAQ:NEOT)’s weekly and monthly volatility is 19.67%, 17.32% respectively. The company’s beta value is at 0.
In terms of Buy, Sell or Hold recommendations, Neothetics Cmn (NASDAQ:NEOT) has analysts’ mean recommendation of 3. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.
Previously Neothetics Cmn (NASDAQ:NEOT) reported $-0.22 earnings per share (EPS) for the quarter, missing the consensus estimate of $-0.19 by $-0.03. The company posted an earnings surprise of -15.8%.
Currently Neothetics Cmn (NASDAQ:NEOT)’s shares owned by insiders are 54.08%, whereas shares owned by institutional owners are 40.5%. However the six-month change in the insider ownership was recorded 0%, as well as three-month change in the institutional ownership was recorded -1.68%.
Neothetics Cmn (NASDAQ:NEOT) 52-week high price stands at $2.63 and low price stands at $0.40, its price distance from 52-week high is -85.67% while its distance from 52-week low price is -6.89%. The stock hit its 52-week high on 05/25/17, and 52-week low on 08/10/17.
Neothetics Cmn (NASDAQ:NEOT)’s trailing twelve month revenues are $0, whereas its price to sales ratio for the same period is 0. Its book value per share for the most recent quarter is $0.65 while its price to book ratio for the same period is 0.58, as for as the company’s cash per share for the most recent quarter is $0.78, however its price to cash per share ratio for the same period is 0.48. The stock has 5 year expected PEG ratio of 0 whereas its trailing twelve month P/E ratio is 0.